Organon & Co | OGN - Ebitda





Ebitda Veränderung Datum
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Celltrion KRW 19.64B 1.85B 2026-03
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -46.46M 6.27M 2026-03
Divis Laboratories Ltd INR 12.62B 3.28B 2026-06
Gilead Sciences USD 3.51B 489M 2026-03
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Merck USD -1.54B 7.84B 2026-03
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Novartis USD 5.41B 431M 2026-03
Organigram Holdings CAD -4.76M 10.02M 2026-03
Organon & Co USD 371M 44M 2026-06
Pharma Mar EUR 700K 2.01M 2026-06
Qiagen NV USD 207.66M 59.56M 2026-06
Sartorius EUR 280.5M 13.2M 2026-06
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -379M 348.47M 2026-03